Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Dezheng Huo and Bruce Brockstein.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.020 |
|
|
|
-
Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EE. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005 Dec 01; 11(23):8418-24.
Score: 0.020